DVA

NEUTRALEarnings

DaVita Inc.

2026-07-24

Price

$235.44

+0.50%

This is the 2026-07-24 snapshot — the signals and analysis for DVA as of this single trading day.

View full DVA research hub →

Score3.0Watchlist

Signals3/8 DNA0/13 Act · 0/4 Risk

SentimentNEUTRALScore: 8

Volume0.7xvs 20d avg

Analysis

DaVita (DVA) is undergoing high-conviction price discovery, perfectly marrying strong technical signals (ALPHA_MALE, PERFECT_STACK) with a major fundamental catalyst after management recently raised Q2 guidance on volume and efficiency gains. The broader CAUTION macro regime—marked by geopolitical fears but stable credit internals—is driving institutional absorption into defensive, high-quality healthcare names. With the stock showing exceptional relative strength (+9.7% vs SPY), the market is aggressively pricing in the upcoming August 4th earnings print despite some value-oriented funds taking profits.

Fired Signals

ALPHA MALEGOLDEN CROSSPERFECT STACK

Key Takeaways

Actionable Thesis: DVA offers a defensive yet high-momentum long setup, supported by raised Q2 guidance [1.2.4], AI-platform integration, and robust technical signaling.
Key Risk: Valuation concerns are emerging, with funds like Moon Capital exiting and insider selling noted, suggesting the stock is priced for perfection.
What to Watch: Monitor the $217.04 support level to ensure the uptrend remains intact amidst broader geopolitical market volatility.

← Back to 2026-07-24 View Full DVA History →Yahoo Finance &nearr;